{"count": 57, "results": [{"_id": "35027504", "pmid": 35027504, "pmcid": "PMC8791222", "title": "The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice", "journal": "Aging (Albany NY)", "authors": ["Zhou Q", "Guan Z", "Liu S", "Xuan Y", "Han G", "Chen H", "Jin X", "Tao K", "Guan Z"], "date": "2022-01-14T00:00:00Z", "doi": "10.18632/aging.203729", "meta_date_publication": "2022 Jan 14", "meta_volume": "14", "meta_issue": "1", "meta_pages": "272-285", "score": 50272.086, "text_hl": "The effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Alendronate @CHEMICAL_MESH:D019386 @@@alendronate@@@ in attenuating @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone loss@@@ and improving @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ metabolism in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ mice", "citations": {"NLM": "Zhou Q, Guan Z, Liu S, Xuan Y, Han G, Chen H, Jin X, Tao K, Guan Z. The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice Aging (Albany NY). 2022 Jan 14;14(1):272-285. PMID: 35027504", "BibTeX": "@article{35027504, title={The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice}, author={Zhou Q and Guan Z and Liu S and Xuan Y and Han G and Chen H and Jin X and Tao K and Guan Z}, journal={Aging (Albany NY)}, volume={14}, number={1}, pages={272-285}}"}}, {"_id": "36284303", "pmid": 36284303, "pmcid": "PMC9594975", "title": "Metformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1", "journal": "Cell Commun Signal", "authors": ["Xie X", "Hu L", "Mi B", "Xue H", "Hu Y", "Panayi AC", "Endo Y", "Chen L", "Yan C", "Lin Z", "Li H", "Zhou W", "Liu G"], "date": "2022-10-25T00:00:00Z", "doi": "10.1186/s12964-022-00966-5", "meta_date_publication": "2022 Oct 25", "meta_volume": "20", "meta_issue": "1", "meta_pages": "165", "score": 50269.977, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates OVX-induced @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone loss@@@ in vivo", "citations": {"NLM": "Xie X, Hu L, Mi B, Xue H, Hu Y, Panayi AC, Endo Y, Chen L, Yan C, Lin Z, Li H, Zhou W, Liu G. Metformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1 Cell Commun Signal. 2022 Oct 25;20(1):165. PMID: 36284303", "BibTeX": "@article{36284303, title={Metformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1}, author={Xie X and Hu L and Mi B and Xue H and Hu Y and Panayi AC and Endo Y and Chen L and Yan C and Lin Z and Li H and Zhou W and Liu G}, journal={Cell Commun Signal}, volume={20}, number={1}, pages={165}}"}}, {"_id": "33437764", "pmid": 33437764, "pmcid": "PMC7791269", "title": "Metformin inhibits inflammation and bone destruction in collagen-induced arthritis in rats", "journal": "Ann Transl Med", "authors": ["Fan KJ", "Wu J", "Wang QS", "Xu BX", "Zhao FT", "Wang TY"], "date": "2020-12-01T00:00:00Z", "doi": "10.21037/atm-20-3042", "meta_date_publication": "2020 Dec", "meta_volume": "8", "meta_issue": "23", "meta_pages": "1565", "score": 50269.418, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone destruction@@@ in collagen-induced @DISEASE_Arthritis @DISEASE_MESH:D001168 @@@arthritis@@@ in rats", "citations": {"NLM": "Fan KJ, Wu J, Wang QS, Xu BX, Zhao FT, Wang TY. Metformin inhibits inflammation and bone destruction in collagen-induced arthritis in rats Ann Transl Med. 2020 Dec;8(23):1565. PMID: 33437764", "BibTeX": "@article{33437764, title={Metformin inhibits inflammation and bone destruction in collagen-induced arthritis in rats}, author={Fan KJ and Wu J and Wang QS and Xu BX and Zhao FT and Wang TY}, journal={Ann Transl Med}, volume={8}, number={23}, pages={1565}}"}}, {"_id": "36555544", "pmid": 36555544, "pmcid": "PMC9779818", "title": "Effects of Metformin Delivery via Biomaterials on Bone and Dental Tissue Engineering", "journal": "Int J Mol Sci", "authors": ["Zhu M", "Zhao Z", "Xu HHK", "Dai Z", "Yu K", "Xiao L", "Schneider A", "Weir MD", "Oates TW", "Bai Y", "Zhang K"], "date": "2022-12-14T00:00:00Z", "doi": "10.3390/ijms232415905", "meta_date_publication": "2022 Dec 14", "meta_volume": "23", "meta_issue": "24", "meta_pages": "", "score": 50261.734, "text_hl": "Importantly, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has demonstrated a significant contribution to repairing @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone defects@@@ and promoting angiogenesis.", "citations": {"NLM": "Zhu M, Zhao Z, Xu HHK, Dai Z, Yu K, Xiao L, Schneider A, Weir MD, Oates TW, Bai Y, Zhang K. Effects of Metformin Delivery via Biomaterials on Bone and Dental Tissue Engineering Int J Mol Sci. 2022 Dec 14;23(24):. PMID: 36555544", "BibTeX": "@article{36555544, title={Effects of Metformin Delivery via Biomaterials on Bone and Dental Tissue Engineering}, author={Zhu M and Zhao Z and Xu HHK and Dai Z and Yu K and Xiao L and Schneider A and Weir MD and Oates TW and Bai Y and Zhang K}, journal={Int J Mol Sci}, volume={23}, number={24}}"}}, {"_id": "32841254", "pmid": 32841254, "pmcid": "PMC7447028", "title": "Impact of hyperglycemia and treatment with metformin on ligature-induced bone loss, bone repair and expression of bone metabolism transcription factors", "journal": "PLoS One", "authors": ["Malta FS", "Garcia RP", "Azarias JS", "Ribeiro GKDR", "Miranda TS", "Shibli JA", "Bastos MF"], "date": "2020-08-25T00:00:00Z", "doi": "10.1371/journal.pone.0237660", "meta_date_publication": "2020", "meta_volume": "15", "meta_issue": "8", "meta_pages": "e0237660", "score": 50260.047, "text_hl": "Impact of @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on ligature-induced @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone loss@@@, bone repair and expression of bone metabolism transcription factors", "citations": {"NLM": "Malta FS, Garcia RP, Azarias JS, Ribeiro GKDR, Miranda TS, Shibli JA, Bastos MF. Impact of hyperglycemia and treatment with metformin on ligature-induced bone loss, bone repair and expression of bone metabolism transcription factors PLoS One. 2020;15(8):e0237660. PMID: 32841254", "BibTeX": "@article{32841254, title={Impact of hyperglycemia and treatment with metformin on ligature-induced bone loss, bone repair and expression of bone metabolism transcription factors}, author={Malta FS and Garcia RP and Azarias JS and Ribeiro GKDR and Miranda TS and Shibli JA and Bastos MF}, journal={PLoS One}, volume={15}, number={8}, pages={e0237660}}"}}, {"_id": "36297386", "pmid": 36297386, "pmcid": "PMC9611301", "title": "The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment", "journal": "Pharmaceuticals (Basel)", "authors": ["Mu W", "Liang G", "Feng Y", "Jiang Y", "Qu F"], "date": "2022-10-17T00:00:00Z", "doi": "10.3390/ph15101274", "meta_date_publication": "2022 Oct 17", "meta_volume": "15", "meta_issue": "10", "meta_pages": "", "score": 50259.168, "text_hl": "The Potential Therapeutic Role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ and Non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@Bone Impairment@@@", "citations": {"NLM": "Mu W, Liang G, Feng Y, Jiang Y, Qu F. The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment Pharmaceuticals (Basel). 2022 Oct 17;15(10):. PMID: 36297386", "BibTeX": "@article{36297386, title={The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment}, author={Mu W and Liang G and Feng Y and Jiang Y and Qu F}, journal={Pharmaceuticals (Basel)}, volume={15}, number={10}}"}}, {"_id": "36398019", "pmid": 36398019, "pmcid": "PMC9643507", "title": "Effects of metformin on the bioactivity and osseointegration of dental implants: A systematic review", "journal": "J Taibah Univ Med Sci", "authors": ["Patel V", "Sadiq MS", "Najeeb S", "Khurshid Z", "Zafar MS", "Heboyan A"], "date": "2022-08-04T00:00:00Z", "doi": "10.1016/j.jtumed.2022.07.003", "meta_date_publication": "2023 Feb", "meta_volume": "18", "meta_issue": "1", "meta_pages": "196-206", "score": 50259.035, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, an anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ drug known for its osteogenic properties, is thought to prevent peri-implant @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone loss@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Patel V, Sadiq MS, Najeeb S, Khurshid Z, Zafar MS, Heboyan A. Effects of metformin on the bioactivity and osseointegration of dental implants: A systematic review J Taibah Univ Med Sci. 2023 Feb;18(1):196-206. PMID: 36398019", "BibTeX": "@article{36398019, title={Effects of metformin on the bioactivity and osseointegration of dental implants: A systematic review}, author={Patel V and Sadiq MS and Najeeb S and Khurshid Z and Zafar MS and Heboyan A}, journal={J Taibah Univ Med Sci}, volume={18}, number={1}, pages={196-206}}"}}, {"_id": "35887957", "pmid": 35887957, "pmcid": "PMC9323116", "title": "Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review", "journal": "J Clin Med", "authors": ["Loh DKW", "Kadirvelu A", "Pamidi N"], "date": "2022-07-19T00:00:00Z", "doi": "10.3390/jcm11144193", "meta_date_publication": "2022 Jul 19", "meta_volume": "11", "meta_issue": "14", "meta_pages": "", "score": 50258.6, "text_hl": "Recently, there have been investigations on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@) as a potential treatment for @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone diseases@@@ such as @DISEASE_Osteoporosis @DISEASE_MESH:D010024 @@@osteoporosis@@@, as researchers have outlined that @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@) poses an increased risk of @DISEASE_Fractures_Bone @DISEASE_MESH:D050723 @@@fractures@@@. ", "citations": {"NLM": "Loh DKW, Kadirvelu A, Pamidi N. Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review J Clin Med. 2022 Jul 19;11(14):. PMID: 35887957", "BibTeX": "@article{35887957, title={Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review}, author={Loh DKW and Kadirvelu A and Pamidi N}, journal={J Clin Med}, volume={11}, number={14}}"}}, {"_id": "37222255", "pmid": 37222255, "title": "The combination of linagliptin and metformin rescues bone loss in type 2 diabetic osteoporosis.", "journal": "J Drug Target", "authors": ["Liu J", "Liu Z", "Lu M", "Zhang Y"], "date": "2023-05-25T00:00:00Z", "doi": "10.1080/1061186X.2023.2216894", "meta_date_publication": "2023 May 25", "meta_volume": "", "meta_issue": "", "meta_pages": "1-9", "score": 50257.598, "text_hl": "The combination of @CHEMICAL_Linagliptin @CHEMICAL_MESH:D000069476 @@@linagliptin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ rescues @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone loss@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetic osteoporosis@@@.", "citations": {"NLM": "Liu J, Liu Z, Lu M, Zhang Y. The combination of linagliptin and metformin rescues bone loss in type 2 diabetic osteoporosis. J Drug Target. 2023 May 25;():1-9. PMID: 37222255", "BibTeX": "@article{37222255, title={The combination of linagliptin and metformin rescues bone loss in type 2 diabetic osteoporosis.}, author={Liu J and Liu Z and Lu M and Zhang Y}, journal={J Drug Target}, pages={1-9}}"}}, {"_id": "33971745", "pmid": 33971745, "title": "Metformin-Incorporated Gelatin/Hydroxyapatite Nanofiber Scaffold for Bone Regeneration.", "journal": "Tissue Eng Part A", "authors": ["Sun CK", "Weng PW", "Chang JZ", "Lin YW", "Tsuang FY", "Lin FH", "Tsai TH", "Sun JS"], "date": "2022-01-01T00:00:00Z", "doi": "10.1089/ten.TEA.2021.0038", "meta_date_publication": "2022 Jan", "meta_volume": "28", "meta_issue": "1-2", "meta_pages": "1-12", "score": 50257.504, "text_hl": "We demonstrated that the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-incorporated NGF greatly improved healing potential on the critical-size @<m>DISEASE_Bone_Diseases</m> @DISEASE_MESH:D001847 @@@bone defect@@@. ", "citations": {"NLM": "Sun CK, Weng PW, Chang JZ, Lin YW, Tsuang FY, Lin FH, Tsai TH, Sun JS. Metformin-Incorporated Gelatin/Hydroxyapatite Nanofiber Scaffold for Bone Regeneration. Tissue Eng Part A. 2022 Jan;28(1-2):1-12. PMID: 33971745", "BibTeX": "@article{33971745, title={Metformin-Incorporated Gelatin/Hydroxyapatite Nanofiber Scaffold for Bone Regeneration.}, author={Sun CK and Weng PW and Chang JZ and Lin YW and Tsuang FY and Lin FH and Tsai TH and Sun JS}, journal={Tissue Eng Part A}, volume={28}, number={1-2}, pages={1-12}}"}}]}